ONCO
Onconetix, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.02
+38.02%Margins
Gross margin
80.4%
EBITDA margin
-1528.7%
EBIT margin
-1265.5%
Net margin
-1578.8%
FCF margin
-1596.1%
-75.7%
Return on equity
-62.1%
Return on assets
-59.9%
Return on invested capital
0.04x
Asset turnover
-$10.3M
Cash from operations
$1.50
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026